MDT

95.62

+0.1%↑

VEEV

286.22

-0.26%↓

A

138.32

+1.29%↑

HQY

93.32

+3.04%↑

PHR.US

22.18

-0.63%↓

MDT

95.62

+0.1%↑

VEEV

286.22

-0.26%↓

A

138.32

+1.29%↑

HQY

93.32

+3.04%↑

PHR.US

22.18

-0.63%↓

MDT

95.62

+0.1%↑

VEEV

286.22

-0.26%↓

A

138.32

+1.29%↑

HQY

93.32

+3.04%↑

PHR.US

22.18

-0.63%↓

MDT

95.62

+0.1%↑

VEEV

286.22

-0.26%↓

A

138.32

+1.29%↑

HQY

93.32

+3.04%↑

PHR.US

22.18

-0.63%↓

MDT

95.62

+0.1%↑

VEEV

286.22

-0.26%↓

A

138.32

+1.29%↑

HQY

93.32

+3.04%↑

PHR.US

22.18

-0.63%↓

Search

Glaukos Corp

Chiusa

SettoreSettore sanitario

83.04 0.63

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

81.99

Massimo

84.61

Metriche Chiave

By Trading Economics

Entrata

-1.5M

-20M

Vendite

17M

124M

Margine di Profitto

-15.837

Dipendenti

995

EBITDA

12M

-8.6M

Raccomandazioni

By TipRanks

Raccomandazioni

Fortemente da comprare

Previsioni per 12 mesi

+40.41% upside

Dividendi

By Dow Jones

Utili prossimi

30 ott 2025

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-456M

5B

Apertura precedente

82.41

Chiusura precedente

83.04

Notizie sul Sentiment di mercato

By Acuity

23%

77%

44 / 371 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Very Strong Bearish Evidence

Glaukos Corp Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

12 ott 2025, 21:50 UTC

Acquisizioni, Fusioni, Takeovers

Caterpillar to Acquire Australia's RPM Global for $730 Million

10 ott 2025, 21:38 UTC

Acquisizioni, Fusioni, Takeovers

Strathcona Resources Terminates Take-Over Bid for MEG Energy

12 ott 2025, 23:47 UTC

Discorsi di Mercato

Gold Rises, Buoyed by Monetary Debasement Fears -- Market Talk

12 ott 2025, 23:39 UTC

Discorsi di Mercato

Oil Rises on Likely Technical Recovery, Mildly Positive Sentiment -- Market Talk

12 ott 2025, 23:22 UTC

Discorsi di Mercato

New Zealand Braces For Renewed Trade War Uncertainty -- Market Talk

12 ott 2025, 23:16 UTC

Acquisizioni, Fusioni, Takeovers

Caterpillar Inc. Enters Into Agreement To Acquire RPMGlobal >CAT RUL.AU

12 ott 2025, 22:32 UTC

Discorsi di Mercato

Copper, U.S. Thermal Coal Stand Out as Metals Ride Macro Tailwinds -- Market Talk

12 ott 2025, 21:28 UTC

Acquisizioni, Fusioni, Takeovers

RPM Global Says Board Unanimously Recommends Shareholders Accept Caterpillar Offer

12 ott 2025, 21:28 UTC

Acquisizioni, Fusioni, Takeovers

RPM Global Agrees to Takeover by Caterpillar

12 ott 2025, 21:28 UTC

Acquisizioni, Fusioni, Takeovers

RPM Global Says Caterpillar Offering A$5.00/Share in Cash

11 ott 2025, 08:20 UTC

Discorsi di Mercato

Financial Services Roundup: Market Talk

11 ott 2025, 00:18 UTC

Acquisizioni, Fusioni, Takeovers

Why Biotech May Be Back -- Barrons.com

10 ott 2025, 21:07 UTC

Utili
Acquisizioni, Fusioni, Takeovers

Dell Is Just Beginning to Tell Its AI Story. Buy the Stock. -- Barrons.com

10 ott 2025, 20:50 UTC

Discorsi di Mercato

Financial Services Roundup: Market Talk

10 ott 2025, 20:50 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

10 ott 2025, 20:50 UTC

Discorsi di Mercato
Acquisizioni, Fusioni, Takeovers

Health Care Roundup: Market Talk

10 ott 2025, 20:06 UTC

Discorsi di Mercato

Fed Won't Publish Monthly Industrial Data Next Week -- Market Talk

10 ott 2025, 20:06 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

10 ott 2025, 19:56 UTC

Discorsi di Mercato

U.S.-China Tension Weighs Down on Treasury Yields, Dollar -- Market Talk

10 ott 2025, 19:20 UTC

Discorsi di Mercato

Oil Futures Sink As Trump Rekindles Trade Tensions -- Market Talk

10 ott 2025, 19:02 UTC

Discorsi di Mercato

U.S. Natural Gas Futures Post Weekly Loss -- Market Talk

10 ott 2025, 18:58 UTC

Discorsi di Mercato

Canada's Jobs Gain Marks a 'Head Fake' For Economy -- Market Talk

10 ott 2025, 18:52 UTC

Discorsi di Mercato

PepsiCo Lays Groundwork for Improvement -- Market Talk

10 ott 2025, 18:47 UTC

Discorsi di Mercato

Precious Metals Turn Higher After Profit-Taking Slide -- Market Talk

10 ott 2025, 18:35 UTC

Discorsi di Mercato

Canada's Next Rate Cut May be Pushed to December -- Market Talk

10 ott 2025, 18:31 UTC

Discorsi di Mercato

Canada's Labor Market Firming. But Conditions Vary Across Country -- Market Talk

10 ott 2025, 17:32 UTC

Discorsi di Mercato

U.S. Oil Rig Count Declines by Four to 418 -- Market Talk

10 ott 2025, 16:55 UTC

Utili

These Stocks Are Moving the Most Today: MP Materials, Nvidia, Alibaba, Venture Global, Applied Digital, Qualcomm, and More -- Barrons.com

10 ott 2025, 16:20 UTC

Discorsi di Mercato

Financial Services Roundup: Market Talk

10 ott 2025, 16:20 UTC

Discorsi di Mercato

Auto & Transport Roundup: Market Talk

Confronto tra pari

Modifica del prezzo

Glaukos Corp Previsione

Obiettivo di Prezzo

By TipRanks

40.41% in crescita

Previsioni per 12 mesi

Media 115.92 USD  40.41%

Alto 165 USD

Basso 92 USD

Basato su 13 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Glaukos Corp - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

13 ratings

11

Acquista

2

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

87.61 / 93Supporto e resistenza

A breve termine

Very Strong Bearish Evidence

A termine intermedio

Bearish Evidence

A lungo termine

Bearish Evidence

Sentiment

By Acuity

44 / 371 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove rialziste molto forti

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Glaukos Corp

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent and iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.
help-icon Live chat